Girard Partners Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Girard Partners Ltd.

  • $1.06 Billion
  • Q2 2024

A detailed history of Girard Partners Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Girard Partners Ltd. holds 10,818 shares of REGN stock, worth $7.65 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
10,818
Previous 10,928 1.01%
Holding current value
$7.65 Million
Previous $10.5 Million 8.1%
% of portfolio
1.08%
Previous 0.99%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$883.2 - $1071.19 $97,152 - $117,830
-110 Reduced 1.01%
10,818 $11.4 Million
Q1 2024

May 13, 2024
BUY
$902.69 - $993.35 $77,631 - $85,428
86 Added 0.79%
10,928 $10.5 Million
Q4 2023

Feb 09, 2024
BUY
$775.18 - $881.7 $196,895 - $223,951
254 Added 2.4%
10,842 $9.52 Million
Q3 2023

Nov 02, 2023
BUY
$692.45 - $844.37 $98,327 - $119,900
142 Added 1.36%
10,588 $8.71 Million
Q2 2023

Aug 15, 2023
SELL
$700.03 - $830.35 $644,727 - $764,752
-921 Reduced 8.1%
10,446 $7.51 Million
Q1 2023

May 12, 2023
BUY
$680.49 - $826.97 $1.92 Million - $2.34 Million
2,828 Added 33.12%
11,367 $9.34 Million
Q4 2022

Jan 26, 2023
BUY
$705.89 - $766.39 $248,473 - $269,769
352 Added 4.3%
8,539 $0
Q3 2022

Oct 20, 2022
BUY
$573.97 - $724.32 $1.16 Million - $1.47 Million
2,024 Added 32.84%
8,187 $5.64 Million
Q2 2022

Jul 26, 2022
SELL
$548.35 - $738.84 $177,665 - $239,384
-324 Reduced 4.99%
6,163 $3.64 Million
Q1 2022

Apr 27, 2022
SELL
$595.12 - $698.43 $112,477 - $132,003
-189 Reduced 2.83%
6,487 $4.53 Million
Q4 2021

Feb 02, 2022
BUY
$543.48 - $670.97 $151,087 - $186,529
278 Added 4.35%
6,676 $4.22 Million
Q3 2021

Nov 01, 2021
BUY
$574.03 - $680.96 $1.45 Million - $1.72 Million
2,527 Added 65.28%
6,398 $3.87 Million
Q3 2021

Nov 01, 2021
SELL
$574.03 - $680.96 $1.41 Million - $1.68 Million
-2,461 Reduced 38.87%
3,871 $3.87 Million
Q2 2021

Aug 10, 2021
BUY
$472.8 - $558.54 $289,826 - $342,385
613 Added 10.72%
6,332 $3.54 Million
Q1 2021

May 06, 2021
BUY
$446.73 - $548.2 $2.55 Million - $3.14 Million
5,719 New
5,719 $2.71 Million
Q4 2018

Feb 11, 2019
SELL
$335.82 - $403.04 $22,499 - $27,003
-67 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$351.14 - $408.51 $23,526 - $27,370
67 New
67 $27,000
Q4 2017

Feb 07, 2018
SELL
$358.63 - $469.95 $167,480 - $219,466
-467 Closed
0 $0
Q3 2017

Nov 08, 2017
SELL
$431.38 - $504.0 $32,784 - $38,304
-76 Reduced 14.0%
467 $209,000
Q2 2017

Aug 08, 2017
BUY
N/A
543
543 $267,000

Others Institutions Holding REGN

# of Institutions
1,489
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.44M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.8B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Girard Partners Ltd. Portfolio

Follow Girard Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Girard Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Girard Partners Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email